Equities research analysts forecast that Coherent, Inc. (NASDAQ:COHR) will announce sales of $409.50 million for the current quarter, according to Zacks. Two analysts have provided estimates for Coherent’s earnings, with the highest sales estimate coming in at $409.90 million and the lowest estimate coming in at $409.10 million. Coherent posted sales of $481.12 million during the same quarter last year, which suggests a negative year-over-year growth rate of 14.9%. The company is expected to issue its next earnings report on Tuesday, May 7th.
On average, analysts expect that Coherent will report full-year sales of $1.69 billion for the current fiscal year, with estimates ranging from $1.67 billion to $1.70 billion. For the next fiscal year, analysts forecast that the company will post sales of $1.72 billion. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Coherent.
Coherent (NASDAQ:COHR) last issued its quarterly earnings data on Tuesday, January 29th. The scientific and technical instruments company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $2.07 by $0.02. The firm had revenue of $383.15 million during the quarter, compared to analyst estimates of $382.65 million. Coherent had a return on equity of 22.22% and a net margin of 13.33%.
In other news, Director Pamela Fletcher sold 458 shares of the business’s stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $132.75, for a total value of $60,799.50. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.25% of the stock is owned by insiders.
Several hedge funds and other institutional investors have recently made changes to their positions in COHR. Vanguard Group Inc. lifted its stake in Coherent by 0.3% in the third quarter. Vanguard Group Inc. now owns 2,185,105 shares of the scientific and technical instruments company’s stock valued at $376,253,000 after purchasing an additional 5,472 shares during the last quarter. Vanguard Group Inc lifted its stake in Coherent by 0.3% in the third quarter. Vanguard Group Inc now owns 2,185,105 shares of the scientific and technical instruments company’s stock valued at $376,253,000 after purchasing an additional 5,472 shares during the last quarter. OppenheimerFunds Inc. lifted its stake in Coherent by 9.0% in the third quarter. OppenheimerFunds Inc. now owns 1,203,046 shares of the scientific and technical instruments company’s stock valued at $207,152,000 after purchasing an additional 99,720 shares during the last quarter. Eagle Asset Management Inc. lifted its stake in Coherent by 3.8% in the third quarter. Eagle Asset Management Inc. now owns 1,183,207 shares of the scientific and technical instruments company’s stock valued at $203,736,000 after purchasing an additional 43,428 shares during the last quarter. Finally, Carillon Tower Advisers Inc. lifted its stake in Coherent by 5.4% in the third quarter. Carillon Tower Advisers Inc. now owns 856,608 shares of the scientific and technical instruments company’s stock valued at $147,882,000 after purchasing an additional 43,595 shares during the last quarter. Hedge funds and other institutional investors own 96.43% of the company’s stock.
COHR traded down $0.03 during midday trading on Friday, reaching $118.20. 485,456 shares of the company were exchanged, compared to its average volume of 433,579. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.02 and a current ratio of 3.32. The firm has a market capitalization of $2.88 billion, a P/E ratio of 9.06 and a beta of 1.57. Coherent has a one year low of $90.10 and a one year high of $270.56.
Coherent, Inc provides lasers, laser-based technologies, and laser-based system solutions for a range of scientific, commercial, and industrial applications. It operates through two segments, OEM Laser Sources and Industrial Lasers & Systems. The company designs, manufactures, markets, and services lasers, laser tools, precision optics, and related accessories; and laser measurement and control products.
See Also: Capital Gains
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Coherent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coherent and related companies with MarketBeat.com's FREE daily email newsletter.